Persistence of genital tract T cell responses in HIV-infected women on highly active antiretroviral therapy

Journal of Virology

Volumn 84, Issue 20, 2010, Pages 10765-10772

  Mkhize, Nonhlanhla N ^a   Gumbi, Pamela P ^a   Liebenberg, Lenine J ^a   Ren, Yuan ^a   Smith, Peter ^a   Denny, Lynette ^a   Passmore, Jo Ann S ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMALE GENITAL SYSTEM; GENITAL TRACT INFLAMMATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; PRIORITY JOURNAL; SOUTH AFRICA; UTERINE CERVIX; UTERINE CERVIX CYTOLOGY; VIREMIA; VIRUS SHEDDING;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; SOUTH AFRICA; T-LYMPHOCYTES; VIREMIA; VIRUS SHEDDING; YOUNG ADULT;

EID: 77957194224     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00518-10     Document Type: Article

References (61)

1. Alatrakchi, N., C. Duvivier, D. Costagliola, A. Samri, A. G. Marcelin, G. Kamkamidze, M. Astriti, R. Agher, V. Calvez, B. Autran, and C. Katlama. 2005. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication. AIDS 19:25-33.
2. Altfeld, M., E. S. Rosenberg, R. Shankarappa, J. S. Mukherjee, F. M. Hecht, R. L. Eldridge, M. M. Addo, S. H. Poon, M. N. Phillips, G. K. Robbins, P. E. Sax, S. Boswell, J. O. Kahn, C. Brander, P. J. Goulder, J. A. Levy, J. I. Mullins, and B. D. Walker. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193:169-180.
3. + T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75.
4. + T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
5. Bazzoli, C., V. Jullien, C. Le Tiec, E. Rey, F. Mentré, and A.-M. Taburet. 2010. Intracellular pharmacokinetics of antiretroviral drugs, and their correlation with drug action. Clin. Pharmacokinet. 49:17-45.
6. Brenchley, J. M., K. S. Knox, A. I. Asher, D. A. Price, L. M. Kohli, E. Gostick, B. J. Hill, C. A. Hage, Z. Brahmi, A. Khoruts, H. L. Twigg III, T. W. Schacker, and D. C. Douek. 2008. High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage. Mucosal Immunol. 1:49-58.
7. + T cells in vivo. J. Virol. 80:6801-6809.
8. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200:749-759.
9. Reference deleted.
10. Chi, J., A. L. Jayewardene, J. A. Stone, et al. 2002. Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS. J. Pharm. Biomed. Anal. 30:675-684.
11. Cohen, M. S., C. Gay, A. D. M. Kashuba, S. Blower, and L. Paxton. 2007. Antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann. Intern. Med. 146:591-601.
12. + T-cell responses during chronic infection reflect clinical status. PLoS One 3:e3577.
13. Reference deleted.
14. Cu-Uvin, S., A. M. Caliendo, S. Reinert, A. Chang, C. Juliano-Remollino, T. P. Flanigan, K. H. Mayer, and C. C. Carpenter. 2000. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 14:415-421.
15. Reference deleted.
16. Dumond, J. B., R. F. Yeh, K. B. Patterson, A. H. Corbett, B. H. Jung, N. L. Rezk, A. S. Bridges, P. W. Stewart, M. S. Cohen, and A. D. Kashuba. 2007. Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS 21:1899-1907.
17. Reference deleted.
18. Reference deleted.
19. Fiore, J. R., B. Suligoi, A. Saracino, M. Di Stefano, R. Bugarini, A. Lepera, A. Favia, L. Monno, G. Angarano, and G. Pastore. 2003. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 17:2169-2176.
20. + T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J. Virol. 79:2709-2719.
21. Graham, S. M., S. E. Holte, N. M. Peshu, B. A. Richardson, D. D. Panteleeff, W. G. Jaoko, J. O. Ndinya-Achola, K. N. Mandaliya, J. M. Overbaugh, and R. S. McClelland. 2007. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 21:501-507.
22. + T cells in individuals receiving highly active antiretroviral therapy (HAART). J. Immunol. 162: 1780-1788.
23. Guadalupe, M., E. Reay, S. Sankaran, T. Prindiville, J. Flamm, A. McNeil, and S. Dandekar. 2003. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77:11708-11717. (Pubitemid 37271669)
24. Guadalupe, M., S. Sankaran, M. D. George, E. Reay, D. Verhoeven, B. L. Shacklett, J. Flamm, J. Wegelin, T. Prindiville, and S. Dandekar. 2006. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J. Virol. 80:8236-8247.
25. Gumbi, P. P., N. N. Nkwanyana, A. Bere, W. A. Burgers, C. M. Gray, A. L. Williamson, M. Hoffman, D. Coetzee, L. Denny, and J. A. Passmore. 2008. Impact of mucosal inflammation on cervical human immunodeficiency virus (HIV-1)-specific CD8 T-cell responses in the female genital tract during chronic HIV infection. J. Virol. 82:8529-8536.
26. Hladik, F., P. Sakchalathorn, L. Ballweber, G. Lentz, M. Fialkow, D. Eschenbach, and M. J. McElrath. 2007. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26:257-270.
27. Holtgrave, D. R. 2005. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both? Int. J. STD AIDS 16:777-781.
28. Reference deleted.
29. Joint United Nations Programme on HIV/AIDS (UNAIDS). March 2008. Sub-Saharan Africa AIDS epidemic update: regional summary, 2007. UNAIDS, Geneva, Switzerland. http://data.unaids.org/pub/Report/2008 /jc1526-epibriefs- subsaharanafrica-en.pdf.
30. Kader, M., W. M. Hassan, M. Eberly, M. Piatak, J. D. Lifson, M. Roederer, and J. J. Mattapallil. 2008. Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection. J. Virol. 82:11467-11471.
31. Kalams, S. A., P. J. Goulder, A. K. Shea, N. G. Jones, A. K. Trocha, G. S. Ogg, and B. D. Walker. 1999. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J. Virol. 73:6721-6728.
32. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J. Immunol. 164:1602-1611.
33. Kaul, R., S. L. Rowland-Jones, J. Kimani, K. Fowke, T. Dong, P. Kiama, J. Rutherford, E. Njagi, F. Mwangi, T. Rostron, J. Onyango, J. Oyugi, K. S. MacDonald, J. J. Bwayo, and F. A. Plummer. 2001. New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol. Lett. 79:3-13.
34. Kwara, A., A. Delong, N. Rezk, J. Hogan, H. Burtwell, S. Chapman, C. C. Moreira, J. Kurpewski, J. Ingersoll, A. M. Caliendo, A. Kashuba, and S. Cu-Uvin. 2008. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. Clin. Infect. Dis. 46:719-725.
35. Lambotte, O., F. Boufassa, Y. Madec, A. Nguyen, C. Goujard, L. Meyer, C. Rouzioux, A. Venet, J. F. Delfraissy, and the SEROCO-MEMOCO Study Group. 2005. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin. Infect. Dis. 41: 1694.
36. + T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 1:475-488.
37. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
38. Mehandru, S., M. A. Poles, K. Tenner-Racz, P. Jean-Pierre, V. Manuelli, P. Lopez, A. Shet, A. Low, H. Mohri, D. Boden, P. Racz, and M. Markowitz. 2006. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 3:e484.
39. Mistri, H. N., A. G. Jangid, A. Pudage, N. Gomes, M. Sanyal, and P. Shrivastav. 2007. High throughput LC-MS/MS method for simultaneous quantification of lamivudine, stavudine and nevirapine in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 853:320-332.
40. National Department of Health, South Africa. 2004. National antiretroviral treatment guidelines. National Department of Health, Pretoria, South Africa.
41. Nkwanyana, N. N., P. P. Gumbi, L. Roberts, L. Denny, W. Hanekom, A. Soares, B. Allan, A. L. Williamson, D. Coetzee, A. J. Olivier, W. A. Burgers, and J. A. Passmore. 2009. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract. Immunology 128:e746-e757.
42. Ogg, G. S., X. Jin, S. Bonhoeffer, P. R. Dunbar, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D. D. Ho, D. F. Nixon, and A. J. McMichael. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-2106.
43. Ogg, G. S., X. Jin, S. Bonhoeffer, P. Moss, M. A. Nowak, S. Monard, J. P. Segal, Y. Cao, S. L. Rowland-Jones, A. Hurley, M. Markowitz, D. D. Ho, A. J. McMichael, and D. F. Nixon. 1999. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy. J. Virol. 73:797-800.
44. + T-cell responses in subjects treated early after infection. J. Virol. 76:411-415.
45. Ostrowski, S. R., T. L. Katzenstein, P. T. Thim, B. K. Pedersen, J. Gerstoft, and H. Ullum. 2005. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy. J. Infect. Dis. 191:348-357.
46. + T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 97:3382-3387.
47. Pereyra, F., S. Palmer, T. Miura, B. L. Block, A. Wiegand, A. C. Rothchild, B. Baker, R. Rosenberg, E. Cutrell, M. S. Seaman, J. M. Coffin, and B. D. Walker. 2009. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J. Infect. Dis. 200:984-990.
48. + T cells in semen during HIV infection and their restoration following antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 50:283-289.
49. Reference deleted.
50. Rehle, T., O. Shisana, V. Pillay, K. Zuma, A. Puren, and W. Parker. 2007. National HIV incidence measures - new insights into the South African epidemic. S. Afr. Med. J. 97:194-199.
51. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-763.
52. Shacklett, B. L., S. Cu-Uvin, T. J. Beadle, C. A. Pace, N. M. Fast, S. M. Donahue, A. M. Caliendo, T. P. Flanigan, C. C. Carpenter, and D. F. Nixon. 2000. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface. AIDS 14:1911-1915.
53. + T cells in chronic human immunodeficiency virus infection. Blood 96:3094-3101.
54. Sheth, P. M., D. Chege, L. Y. Shin, S. Huibner, F. Y. Yue, M. Loutfy, R. Halpenny, D. Persad, C. Kovacs, T. W. Chun, G. Kandel, M. Ostrowski, and R. Kaul. 2008. Immune reconstitution in the sigmoid colon after long-term HIV therapy. Mucosal Immunol. 1:382-388.
55. + T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol. Biol. 304:3-15.
56. Reference deleted.
57. Tincati, C., M. Biasin, A. Bandera, M. Violin, G. Marchetti, L. Piacentini, G. L. Vago, C. Balotta, M. Moroni, F. Franzetti, M. Clerici, and A. Gori. 2009. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection. Antivir. Ther. 14(3):321-330.
58. Reference deleted.
59. Wendland, T., H. Furrer, P. L. Vernazza, K. Frutig, A. Christen, L. Matter, R. Malinverni, and W. J. Pichler. 1999. HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia. AIDS 13:1857-1862.
60. + anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia. J. Infect. Dis. 180:68-75.
61. World Health Organization (WHO), HIV/AIDS Programme. 2006. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision). World Health Organization, Geneva, Switzerland. http://www.who.int/hiv/pub/arv/adult/en/index .html.